2021 Q4 Form 10-Q Financial Statement

#000155837021015655 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $25.89M $31.28M $12.03M
YoY Change 139.54% 160.02% 11930.0%
% of Gross Profit
Research & Development $58.77M $56.89M $29.97M
YoY Change 111.78% 89.85% 11425.38%
% of Gross Profit
Depreciation & Amortization $0.00 $11.11M $0.00
YoY Change
% of Gross Profit
Operating Expenses $84.66M $99.28M $42.00M
YoY Change 119.62% 136.39% 11899.71%
Operating Profit -$99.28M -$42.00M
YoY Change 136.39%
Interest Expense -$196.0K $9.000K -$557.0K
YoY Change -198.0% -101.62%
% of Operating Profit
Other Income/Expense, Net $3.709M $3.467M $58.00K
YoY Change 50.77% 5877.59% -680.0%
Pretax Income -$81.15M -$95.81M -$42.50M
YoY Change 112.21% 125.44% 11385.95%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$81.15M -$95.81M -$42.50M
YoY Change 112.21% 125.44% 11385.95%
Net Earnings / Revenue
Basic Earnings Per Share -$0.54
Diluted Earnings Per Share -$420.1K -$535.9K -$257.7K
COMMON SHARES
Basic Shares Outstanding 192.2M 177.0M
Diluted Shares Outstanding 178.8M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $244.0M $233.8M $19.60M
YoY Change -61.26% 1093.02%
Cash & Equivalents $244.0M $233.8M $19.71M
Short-Term Investments
Other Short-Term Assets $47.12M $22.92M $4.800M
YoY Change 90.77% 377.42%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $291.1M $256.7M $24.40M
YoY Change -55.51% 952.24%
LONG-TERM ASSETS
Property, Plant & Equipment $382.7M $362.4M $21.70M
YoY Change 276.49% 1570.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.90M $4.750M $100.0K
YoY Change 4650.0%
Total Long-Term Assets $397.6M $367.1M $33.00M
YoY Change 252.6% 1012.55%
TOTAL ASSETS
Total Short-Term Assets $291.1M $256.7M $24.40M
Total Long-Term Assets $397.6M $367.1M $33.00M
Total Assets $688.8M $623.9M $57.40M
YoY Change -10.22% 986.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.10M $48.67M $22.40M
YoY Change -62.82% 117.26%
Accrued Expenses $35.51M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $63.50M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $147.6M $87.85M $101.7M
YoY Change 333.19% -13.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $1.000M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $1.578M $3.529M
YoY Change -98.44%
Total Long-Term Liabilities $1.578M $3.529M $1.000M
YoY Change 57.8% 252.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $147.6M $87.85M $101.7M
Total Long-Term Liabilities $1.578M $3.529M $1.000M
Total Liabilities $149.2M $91.38M $102.7M
YoY Change 9.31% -11.02%
SHAREHOLDERS EQUITY
Retained Earnings -$544.8M -$463.7M
YoY Change 305.24%
Common Stock $19.00K $18.00K
YoY Change 11.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $539.6M $532.5M -$45.34M
YoY Change
Total Liabilities & Shareholders Equity $688.8M $623.9M $57.40M
YoY Change -10.22% 986.91%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$81.15M -$95.81M -$42.50M
YoY Change 112.21% 125.44% 11385.95%
Depreciation, Depletion And Amortization $0.00 $11.11M $0.00
YoY Change
Cash From Operating Activities -$141.8M -$74.87M -$24.21M
YoY Change 393.56% 209.21% 34488.57%
INVESTING ACTIVITIES
Capital Expenditures -$29.99M -$79.93M $0.00
YoY Change -48.51%
Acquisitions
YoY Change
Other Investing Activities $4.000K
YoY Change
Cash From Investing Activities -$29.99M -$79.93M $4.000K
YoY Change -48.51% -1998275.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 181.9M 22.72M 43.33M
YoY Change -73.9% -47.56% 10733.0%
NET CHANGE
Cash From Operating Activities -141.8M -74.87M -24.21M
Cash From Investing Activities -29.99M -79.93M 4.000K
Cash From Financing Activities 181.9M 22.72M 43.33M
Net Change In Cash 10.18M -132.1M 19.12M
YoY Change -98.33% -790.59% 5695.15%
FREE CASH FLOW
Cash From Operating Activities -$141.8M -$74.87M -$24.21M
Capital Expenditures -$29.99M -$79.93M $0.00
Free Cash Flow -$111.8M $5.061M -$24.21M
YoY Change -478.6% -120.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
4000000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
dei Entity Central Index Key
EntityCentralIndexKey
0001759546
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168000000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
182100000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168007960
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
182074899
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38821
dei Entity Registrant Name
EntityRegistrantName
Lordstown Motors Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2533239
dei Entity Address Address Line1
EntityAddressAddressLine1
2300 Hallock Young Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Lordstown
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
44481
dei City Area Code
CityAreaCode
234
dei Local Phone Number
LocalPhoneNumber
285-4001
dei Security12b Title
Security12bTitle
Class A Common Stock
dei Trading Symbol
TradingSymbol
RIDE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
192230903
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
233831000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
629761000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22916000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24663000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
256747000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
654445000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
362391000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101663000
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
11111000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4750000
CY2021Q3 us-gaap Assets
Assets
623888000
CY2020Q4 us-gaap Assets
Assets
767219000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
48666000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
32536000
CY2021Q3 ride Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
39187000
CY2020Q4 ride Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
1538000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
87853000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34074000
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1015000
CY2021Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3529000
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
101392000
CY2021Q3 us-gaap Liabilities
Liabilities
91382000
CY2020Q4 us-gaap Liabilities
Liabilities
136481000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
182074899
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
168007960
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
18000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
17000
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
996146000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
765162000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-463658000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-134441000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
532506000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
630738000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
623888000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
767219000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
31281000
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12033000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
79468000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20710000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
56890000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29966000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
225246000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43220000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11111000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11111000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
99282000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
41999000
us-gaap Operating Expenses
OperatingExpenses
315825000
us-gaap Operating Expenses
OperatingExpenses
63930000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-99282000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-41999000
us-gaap Operating Income Loss
OperatingIncomeLoss
-315825000
us-gaap Operating Income Loss
OperatingIncomeLoss
-63930000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3467000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
58000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13788000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2530000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
9000
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-557000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
396000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-921000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-95806000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-42498000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-329217000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62321000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-95806000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-42498000
us-gaap Net Income Loss
NetIncomeLoss
-329217000
us-gaap Net Income Loss
NetIncomeLoss
-62321000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.57
CY2020Q4 ride Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
2700000
CY2020Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
30700000
CY2021Q1 ride Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
600000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.86
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
178761000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
73951000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
176573000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
73273000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
599003000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2724000
CY2021Q3 ride Stock Issued During Period Value Equity Line Of Credit
StockIssuedDuringPeriodValueEquityLineOfCredit
20000000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6585000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-95806000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
532506000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-3549000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
708000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-42498000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-45339000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
630738000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3822000
ride Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
194798000
ride Stock Issued During Period Value Equity Line Of Credit
StockIssuedDuringPeriodValueEquityLineOfCredit
20000000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12365000
us-gaap Net Income Loss
NetIncomeLoss
-329217000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
532506000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
8556000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6404000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2022000
us-gaap Net Income Loss
NetIncomeLoss
-62321000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-45339000
us-gaap Net Income Loss
NetIncomeLoss
-329217000
us-gaap Net Income Loss
NetIncomeLoss
-62321000
us-gaap Share Based Compensation
ShareBasedCompensation
12365000
us-gaap Share Based Compensation
ShareBasedCompensation
2022000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
14918000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11111000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1015000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2346000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-21000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3001000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4794000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10929000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20587000
ride Increase Decrease In Accrued Liabilities And Due To Related Party
IncreaseDecreaseInAccruedLiabilitiesAndDueToRelatedParty
37649000
ride Increase Decrease In Accrued Liabilities And Due To Related Party
IncreaseDecreaseInAccruedLiabilitiesAndDueToRelatedParty
11267000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-246240000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35605000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
255528000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2396000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-255528000
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
82000000.0
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
629761000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2159000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
233831000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19707000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
55.8817
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 ride Conversion Of Stock Shares Issued Per Share Tendered
ConversionOfStockSharesIssuedPerShareTendered
1
CY2020Q4 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
7000000
CY2020Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000000
CY2020Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.00
CY2020Q4 ride Stock Issued During Period Value Recapitalization
StockIssuedDuringPeriodValueRecapitalization
644600000
CY2020Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
500000000
CY2020Q4 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
40000000
CY2020Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.00
CY2020Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1600000
CY2020Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.00
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2396000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
82016000
ride Proceeds From Equity Based Line Of Credit
ProceedsFromEquityBasedLineOfCredit
20000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3822000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6404000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
44353000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
105838000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50757000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-395930000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17548000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
233800000
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
100900000
CY2020Q4 ride Proceeds From Recapitalization
ProceedsFromRecapitalization
701500000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-463700000
us-gaap Net Income Loss
NetIncomeLoss
-329200000
us-gaap Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
true
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Reclassifications</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';"> </span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;">The Company reclassified $2.3 million of gain on sale of fixed assets to <span style="-sec-ix-hidden:Hidden_cjZfu9V15k2EszSp3xhhKA;"><span style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:justify;">other</span></span> income during the nine months ended September 30, 2020 in order to consistently present its condensed consolidated financial statements. The reclassification did not impact net loss.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Immaterial Correction of Error </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company’s previously issued financial statements have been revised to reclassify certain expenses that were inappropriately presented within the consolidated statement of operations. This resulted in the reclassification of $2.7 million of research and development expenses to <span style="-sec-ix-hidden:Hidden_qUD_TI1SPEmyXtWPRbmMTA;"><span style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">selling</span></span><span style="white-space:pre-wrap;"> and administrative expenses for the nine months ended September 30, 2020. The error did not impact net loss.</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;">The Company, in consultation with the Audit Committee of the Board of Directors, evaluated the effect of these adjustments on the Company’s consolidated financial statements under ASC 250, <i style="font-style:italic;">Accounting Changes </i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">and Error Corrections </i>and Staff Accounting Bulletin No. 108, <i style="font-style:italic;">Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements</i> and determined it was not necessary to recall its consolidated condensed financial statements as the errors did not materially misstate those consolidated financial statements. The Company looked at both quantitative and qualitative characteristics of the required corrections.</p>
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11100000
us-gaap Derivatives Embedded Derivatives
DerivativesEmbeddedDerivatives
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Warrants</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The Company accounts for its Public and Private Warrants as described in Note 3 in accordance with the guidance contained in ASC Topic 815-40-15-7D and 7F under which the Public Warrants and Private Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Public and Private Warrants as liabilities at their fair value and adjusts the Public and Private Warrants to fair value at each reporting period or at the time of settlement. Any change in fair value is recognized in the statement of operations as Other income/(expense).</span></p>
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3344000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
14918000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
362391000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
101663000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
362391000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101663000
us-gaap Depreciation
Depreciation
0
us-gaap Depreciation
Depreciation
0
CY2019Q4 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
20000000.0
CY2020Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2300000
CY2020Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
37800000
CY2020Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
4000000
CY2021Q3 ride Litigation Number Of Stockholder Demands For Records
LitigationNumberOfStockholderDemandsForRecords
8
CY2021Q3 ride Shares Authorized Common And Preferred
SharesAuthorizedCommonAndPreferred
312000000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12000000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
182100000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
168000000.0
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
178761000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
73951000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
176573000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
73273000

Files In Submission

Name View Source Status
0001558370-21-015655-index-headers.html Edgar Link pending
0001558370-21-015655-index.html Edgar Link pending
0001558370-21-015655.txt Edgar Link pending
0001558370-21-015655-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
ride-20210930.xsd Edgar Link pending
ride-20210930x10q.htm Edgar Link pending
ride-20210930x10q_htm.xml Edgar Link completed
ride-20210930xex31d1.htm Edgar Link pending
ride-20210930xex31d2.htm Edgar Link pending
ride-20210930xex32d1.htm Edgar Link pending
ride-20210930xex32d2.htm Edgar Link pending
ride-20210930_cal.xml Edgar Link unprocessable
ride-20210930_def.xml Edgar Link unprocessable
ride-20210930_lab.xml Edgar Link unprocessable
ride-20210930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending